Asia Pacific Leukemia Consortium
Changing the
Status Quo of Leukemia
Coming Up:
3rd APLC Summit Meeting
8-9 November 2025 | Penang, Malaysia.
About Us
The Asia-Pacific Leukemia Consortium (APLC) is a not for profit initiative to improve the management of leukemia and related diseases in the Asia-Pacific (APAC) region. The group aims to address the growing threat of leukemia in APAC region through a collaborative approach to advance disease prevention, patient care, research, clinical trials, and education.
Introduction
As the world’s population continues to rapidly grow and age, cancer incidence, prevalence and mortality are also on the rise.
Despite the advancement in medical technology, drug development, cancer prevention strategies there remains a huge divide to bridge in terms of access to drugs, optimizing treatment, translating trial data for a heterogeneous real-world Asia-Pacific population.
Our Mission
To improve the management of leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.
Our Focus Areas
-
Clinical Trials
-
Disease Registry
-
Genetic & Tissue Repository
-
Education
-
Patient Advocacy & Care
Our Working Groups
-
Acute Myeloid Leukemia (AML)
-
Acute Lymphoblastic Leukemia (ALL)
-
Other Related Diseases (ORD)
Executive Committee
Key Appointment Holders
Executive Committee
Other Members
Our
Working Groups
-
Acute Myeloid Leukemia (AML)
-
Acute Lymphoblastic Leukemia (ALL)
-
Other Related Diseases (ORD)
Our
Focus Areas
-
Clinical Trials
-
Disease Registry
-
Genetic & Tissue Repository
-
Education
-
Patient Advocacy & Care
Our Mission
To improve the management of leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.
NAME
REGION
ORGANISATION
Honorary Members
Peter MacCallum Cancer Centre and The Royal Melbourne Hospital
Dr Lynette Chee
Australia
Peter MacCallum Cancer Centre
Dr Nisha Thiagarajah
Australia
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Prof Hui Wei
China
Peking Union Medical College Hospital
Dr Jian Li
China
West China Hospital of Sichuan University
Prof Wu Yu
China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Dr Ying Wang
China
Nanfang Hospital, Southern Medical University
Prof Zhou Hongsheng
China
The First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Hospital
Dr Zhu Xiaoyu
China
Queen Mary Hospital
Dr Carol Cheung Yuk Man
Hong Kong
University Malaya Medical Centre
Prof Bee Ping-Chong
Malaysia
Hospital Ampang, Selangor
Dr Ho Kim Wah
Malaysia
Gleneagles Hosp, KL
Dr Jay Suriar
Malaysia
Hospital Sultanah Aminah Johor Bahru
Dr Lim Soo Min
Malaysia
Penang General Hospital
Dr Tan Sui Keat
Malaysia
Tan Tock Seng Hospital
Dr Dheepa Christopher
Singapore
National University Cancer Institute Singapore
Dr Jen Wei Ying
Singapore
National University Cancer Institute Singapore
A/Prof Koh Liang Piu
Singapore
Singapore General Hospital
Dr Nurul Aidah Abdul Halim
Singapore
Tan Tock Seng Hospital
Dr Venkata Sreekanth Sampath
Singapore
Singapore General Hospital
Prof Wong Gee Chuan
Singapore
National University Cancer Institute Singapore
Dr Lui Pak Ling
Singapore
King Chulalongkorn University
A/Prof Chantana Polprasert
Thailand
Khon Kaen University Hospital
Dr Chinadol Wanitpongpun
Thailand
Chiang Mai University Hospital
A/Prof Thanawat Rattanathammethee
Thailand
Thammasat University Hospital
A/Prof Wasithep Limvorapitak
Thailand
NAME
REGION
ORGANISATION
Key Opinion Leaders
The 2nd APLC Summit in Chiang Mai highlighted advancements in leukemia management, focusing on innovative therapies, regional collaboration, and access to care. Key topics included FLT3-mutant AML, immunotherapy in ALL, targeted therapies in CLL, and optimized TKIs for CML. Industry innovations, standardized MRD protocols, and regional registries were emphasized, alongside plans for broader collaboration and future conferences, starting in Penang, Malaysia, in 2025. This year saw a total attendance of 69 delegates, guests, and industry partners (including virtual).
Explore this landmark event's highlights through our photo gallery and video recordings available here, or visit our YouTube channel for more. Should you encounter any viewing issues, please reach out to us at APLC contact for assistance .
What's New?
Event Media Centre
Contact
Feel free to ask any questions or share your interests regarding our events. This will help us tailor our communication to better suit your needs. Rest assured, your information will be kept confidential and used solely to address your questions or requests.
Stay tuned for more information. We look forward to connecting with you and answering your queries.
Main Office:
c/o: Singapore General Hospital
Outram Road,
Singapore 169608
Phone :
Email :
Website:
